News
Stay up to date on the latest company news:
09 October 2024
²»Á¼Ñо¿Ëù Appoints Gerben Moolhuizen as Chief Executive Officer
18 March 2024
²»Á¼Ñо¿Ëù selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)
18 October 2022
²»Á¼Ñо¿Ëù Appoints Thomas Bogenrieder as Chief Medical Officer
12 August 2022
²»Á¼Ñо¿Ëù---arenaviruses take on cancer
14 October 2021
²»Á¼Ñо¿Ëù Completes Series A Extension Bringing Total Raised to EUR 43 Million
05 February 2020
²»Á¼Ñо¿Ëù Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts
15 October 2019
²»Á¼Ñо¿Ëù Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer
Events
Want to get in touch with the ²»Á¼Ñо¿Ëù Team? Meet us at the following events:
October 27-30, 2024
IOVC 16th Annual International Oncolytic Virotherapy Conference 2024
Location: Rotterdam, NL
Presentation: 2 posters
Presenters: Jörg Vollmer, CSO; Sarah-Kim Friedrich-Becker, Senior Principal Scientist
Date: October 27-30, 2024
November 4-6, 2024
BIO-Europe
Location: Stockholm, Sweden
Date: November 4-6, 2024
January 13-16, 2025
J.P. Morgan Healthcare Conference 2025
Location: San Francisco, USA
Date: January 13-16, 2025